For example, tumors can produce inhibitory factors, such as transforming growth factor-β (TGF-β) and vascular endothelial growth factor (VEGF), leading to the reduced dendritic cell activation and impaired tumor-specific T cell immunity [1]. The gene discussed is VEGFA; the disease is neoplasm.